Correlation Between Natera and 10X Genomics

Can any of the company-specific risk be diversified away by investing in both Natera and 10X Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Natera and 10X Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Natera Inc and 10X Genomics, you can compare the effects of market volatilities on Natera and 10X Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Natera with a short position of 10X Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Natera and 10X Genomics.

Diversification Opportunities for Natera and 10X Genomics

-0.36

Correlation Coefficient

Natera  10X Genomics

Very good diversification

The 3 months correlation between Natera and 10X is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Natera Inc and 10X Genomics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 10X Genomics and Natera is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Natera Inc are associated (or correlated) with 10X Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 10X Genomics has no effect on the direction of Natera i.e., Natera and 10X Genomics go up and down completely randomly.

Pair Corralation between Natera and 10X Genomics

Given the investment horizon of 90 days Natera Inc is expected to under-perform the 10X Genomics. But the stock apears to be less risky and, when comparing its historical volatility, Natera Inc is 1.8 times less risky than 10X Genomics. The stock trades about -0.1 of its potential returns per unit of risk. The 10X Genomics is currently generating about 0.22 of returns per unit of risk over similar time horizon. If you would invest  831.00  in 10X Genomics on May 7, 2025 and sell it today you would earn a total of  537.00  from holding 10X Genomics or generate 64.62% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Natera Inc  vs.  10X Genomics

Natera Inc

Risk-Adjusted Performance

Very Weak

Over the last 90 days Natera Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in September 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

10X Genomics

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in 10X Genomics are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, 10X Genomics reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Natera and 10X Genomics

The main advantage of trading using opposite Natera and 10X Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Natera position performs unexpectedly, 10X Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 10X Genomics will offset losses from the drop in 10X Genomics' long position.

The idea behind Natera Inc and 10X Genomics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.